
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
For Vince Canzanese, RPh, director of compounding for Burmans Pharmacy, building patient trust relies on a key factor: not allowing a mailman to become the pharmacist.
For Vince Canzanese, RPh, director of compounding for
“Primarily, we build trust with the patients because we’re a community-based organization,” he says. “We’re here, it’s brick-and-mortar, someone can come in and see me, they know who they’re talking to. It’s not just a voice on the phone.”






